Skip to main content

Table 1 The large-scale human microRNA target networks

From: Comprehensive analysis of human microRNA target networks

MicroRNA

Number of Targets

Molecules in KeyMolnet Networks

Top Pathway

Score

p-Value

Top Disease

Score

p-Value

Top Pathological Event

Score

p-Value

hsa-let-7a

244

1022

Transcriptional regulation by p53

593

2.69E-179

Viral myocarditis

113

1.21E-34

Cancer

206

1.31E-62

hsa-let-7b

242

1016

Transcriptional regulation by p53

594

1.83E-179

Viral myocarditis

113

9.32E-35

Cancer

206

7.66E-63

hsa-let-7c

243

1020

Transcriptional regulation by p53

593

2.49E-179

Viral myocarditis

113

1.11E-34

Cancer

206

1.10E-62

hsa-let-7d

145

885

Transcriptional regulation by RB/E2F

836

2.18E-252

Chronic myelogenous leukemia

72

1.95E-22

Cancer

130

9.68E-40

hsa-let-7e

236

1111

Transcriptional regulation by p53

575

8.90E-174

Viral myocarditis

116

1.20E-35

Cancer

175

1.86E-53

hsa-let-7f

244

1022

Transcriptional regulation by p53

593

2.69E-179

Viral myocarditis

113

1.21E-34

Cancer

206

1.31E-62

hsa-let-7g

245

1022

Transcriptional regulation by p53

593

2.69E-179

Viral myocarditis

113

1.21E-34

Cancer

206

1.31E-62

hsa-let-7i

245

1022

Transcriptional regulation by p53

593

2.69E-179

Viral myocarditis

113

1.21E-34

Cancer

206

1.31E-62

hsa-miR-9

352

1115

Transcriptional regulation by PPARa

340

5.28E-103

Hepatocellular carcinoma

72

1.69E-22

Cancer

171

3.50E-52

hsa-miR-17

195

961

Transcriptional regulation by RB/E2F

971

3.27E-293

Chronic myelogenous leukemia

92

2.83E-28

Cancer

181

3.58E-55

hsa-miR-19a

226

1094

Transcriptional regulation by RB/E2F

760

2.10E-229

Chronic myelogenous leukemia

113

1.26E-34

Cancer

253

7.04E-77

hsa-miR-19b

225

1094

Transcriptional regulation by RB/E2F

760

2.10E-229

Chronic myelogenous leukemia

113

1.26E-34

Cancer

253

7.04E-77

hsa-miR-20a

165

1038

Transcriptional regulation by RB/E2F

856

1.64E-258

Chronic myelogenous leukemia

87

6.09E-27

Cancer

85

3.33E-26

hsa-miR-20b

198

981

Transcriptional regulation by RB/E2F

962

2.35E-290

Chronic myelogenous leukemia

98

3.39E-30

Cancer

183

6.98E-56

hsa-miR-26a

148

672

Transcriptional regulation by RB/E2F

919

1.76E-277

Chronic myelogenous leukemia

107

6.15E-33

Cancer

181

3.20E-55

hsa-miR-26b

148

672

Transcriptional regulation by RB/E2F

919

1.76E-277

Chronic myelogenous leukemia

107

6.15E-33

Cancer

181

3.20E-55

hsa-miR-27a

229

1192

Transcriptional regulation by CREB

1022

2.23E-308

Chronic myelogenous leukemia

95

1.96E-29

Cancer

194

3.05E-59

hsa-miR-27b

261

1337

Transcriptional regulation by CREB

1022

2.23E-308

Chronic myelogenous leukemia

94

4.51E-29

Cancer

211

4.11E-64

hsa-miR-29a

119

543

Transcriptional regulation by Ets-domain family

430

4.36E-130

Glioma

85

3.46E-26

Cancer

139

1.41E-42

hsa-miR-29b

118

578

Transcriptional regulation by Ets-domain family

422

1.15E-127

Glioma

82

1.55E-25

Cancer

146

1.44E-44

hsa-miR-29c

118

543

Transcriptional regulation by Ets-domain family

430

4.36E-130

Glioma

85

3.46E-26

Cancer

139

1.41E-42

hsa-miR-30a

455

1494

Transcriptional regulation by RB/E2F

777

9.43E-235

Chronic myelogenous leukemia

86

1.11E-26

Cancer

195

2.39E-59

hsa-miR-30b

455

1480

Transcriptional regulation by RB/E2F

781

1.08E-235

Chronic myelogenous leukemia

87

7.01E-27

Cancer

188

1.92E-57

hsa-miR-30c

454

1495

Transcriptional regulation by RB/E2F

778

6.13E-235

Chronic myelogenous leukemia

86

1.15E-26

Cancer

191

3.63E-58

hsa-miR-30d

452

1491

Transcriptional regulation by RB/E2F

778

7.28E-235

Chronic myelogenous leukemia

86

1.01E-26

Cancer

195

1.96E-59

hsa-miR-30e

455

1481

Transcriptional regulation by RB/E2F

780

1.29E-235

Chronic myelogenous leukemia

87

7.25E-27

Cancer

188

2.05E-57

hsa-miR-32

261

905

Transcriptional regulation by RB/E2F

842

2.74E-254

Gastric cancer

80

8.85E-25

Cancer

157

4.19E-48

hsa-miR-92a

219

642

Transcriptional regulation by MEF2

335

1.51E-101

Viral myocarditis

59

1.62E-18

Epithelial-mesenchymal transition

83

7.76E-26

hsa-miR-92b

258

701

Transcriptional regulation by MEF2

328

1.59E-99

Viral myocarditis

60

1.23E-18

Cancer

94

3.97E-29

hsa-miR-93

195

958

Transcriptional regulation by RB/E2F

972

2.37E-293

Chronic myelogenous leukemia

92

2.47E-28

Cancer

181

2.77E-55

hsa-miR-96

142

688

Transcriptional regulation by Ets-domain family

407

3.42E-123

Viral myocarditis

36

1.06E-11

Cancer

106

1.37E-32

hsa-miR-98

162

671

Transcriptional regulation by Myb

549

4.73E-166

Viral myocarditis

85

2.66E-26

Cancer

126

1.42E-38

hsa-miR-101

188

806

Transcriptional regulation by AP-1

492

1.10E-148

Hepatocellular carcinoma

70

6.40E-22

Cancer

127

4.26E-39

hsa-miR-106b

164

1028

Transcriptional regulation by RB/E2F

854

7.21E-258

Chronic myelogenous leukemia

87

5.48E-27

Cancer

85

2.93E-26

hsa-miR-124

285

1346

Transcriptional regulation by RB/E2F

756

3.57E-228

Chronic myelogenous leukemia

83

9.34E-26

Cancer

185

1.90E-56

hsa-miR-137

288

941

Transcriptional regulation by MITF family

339

1.19E-102

Adult T cell lymphoma/leukemia

66

1.30E-20

Cancer

179

1.00E-54

hsa-miR-147

199

867

Transcriptional regulation by RB/E2F

805

4.06E-243

Chronic myelogenous leukemia

113

6.60E-35

Cancer

132

2.57E-40

hsa-miR-153

154

1019

Transcriptional regulation by Myb

507

2.35E-153

Multiple myeloma

60

6.44E-19

Cancer

174

4.31E-53

hsa-miR-218

155

830

Transcriptional regulation by AP-1

344

2.28E-104

Hepatocellular carcinoma

69

1.63E-21

Cancer

136

1.52E-41

hsa-miR-372

101

562

Transcriptional regulation by RB/E2F

1022

2.23E-308

Chronic myelogenous leukemia

85

1.90E-26

Cancer

144

2.75E-44

hsa-miR-429

123

634

Transcriptional regulation by RB/E2F

918

2.45E-277

Chronic myelogenous leukemia

76

1.71E-23

Cancer

130

5.28E-40

hsa-miR-495

156

601

Transcriptional regulation by Ets-domain family

431

2.14E-130

Rheumatoid arthritis

77

5.90E-24

Adipogenesis

79

1.32E-24

hsa-miR-506

394

1536

Transcriptional regulation by Ets-domain family

317

4.69E-96

Viral myocarditis

99

1.73E-30

Cancer

172

1.43E-52

hsa-miR-519a

281

1256

Transcriptional regulation by RB/E2F

811

5.32E-245

Chronic myelogenous leukemia

106

1.34E-32

Cancer

220

8.03E-67

hsa-miR-519b-3p

281

1256

Transcriptional regulation by RB/E2F

811

5.32E-245

Chronic myelogenous leukemia

106

1.34E-32

Cancer

220

8.03E-67

hsa-miR-519c-3p

281

1256

Transcriptional regulation by RB/E2F

811

5.32E-245

Chronic myelogenous leukemia

106

1.34E-32

Cancer

220

8.03E-67

hsa-miR-520a-3p

184

690

Transcriptional regulation by RB/E2F

1022

2.23E-308

Chronic myelogenous leukemia

94

6.95E-29

Cancer

146

1.12E-44

hsa-miR-520b

182

690

Transcriptional regulation by RB/E2F

1022

2.23E-308

Chronic myelogenous leukemia

94

6.95E-29

Cancer

146

1.12E-44

hsa-miR-520c-3p

182

690

Transcriptional regulation by RB/E2F

1022

2.23E-308

Chronic myelogenous leukemia

93

9.28E-29

Cancer

145

1.77E-44

hsa-miR-520d-3p

183

690

Transcriptional regulation by RB/E2F

1022

2.23E-308

Chronic myelogenous leukemia

94

6.95E-29

Cancer

146

1.12E-44

hsa-miR-520e

184

690

Transcriptional regulation by RB/E2F

1022

2.23E-308

Chronic myelogenous leukemia

94

6.95E-29

Cancer

146

1.12E-44

hsa-miR-603

252

1150

Transcriptional regulation by Ets-domain family

344

3.26E-104

Multiple myeloma

84

4.36E-26

Cancer

161

4.24E-49

  1. Among 1,223 human miRNAs examined, Diana-microT 3.0 predicted reliable targets from 273 miRNAs. Among them, KeyMolnet extracted molecular networks from 232 miRNAs. The generated network was compared side by side with human canonical networks of the KeyMolnet library, composed of 430 pathways, 885 diseases, and 208 pathological events. The canonical pathways, diseases, and pathological events with the most statistically significant contribution to the extracted network are shown. The table contains only the large-scale miRNA target networks generated by importing targets greater than 100 per individual miRNA into KeyMolnet. See Additional file 1 for all the information on 232 miRNAs and their target networks.